HALOZYME THERAPEUTICS, INC. - COM (HALO)

Q1 2023 13F Holders as of 3/31/2023

Type / Class
Equity / COM
Number of holders
381
Total Shares
124M
Shares change
-4.15M
Total reported value, excl. options
$4.72B
Value change
-$280M
Put/Call ratio
0.39
Number of buys
182
Number of sells
-224
Price
$38.19
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.